In this study, to increase the understanding of how interactions between mutant p53, mutant KRAS, and c-Myc affect their downstream programs, we systematically surveyed the transcriptomics and proteomics programs of the oncogenes in a panel of colon, lung, and pancreatic cancer cell lines. This evidence concerns the gene KRAS and pancreatic neoplasm.